home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

A Modelling Study on Variant Creutzfeld-Jacob Disease Mortality

 
  August, 14 2000 6:01
your information resource in human molecular genetics
 
     
MORE ON vCJD MORTALITY

A modelling study reported in Nature [Vol. 406, Issue 6796 (2000), p. 583] predicts that, on average, no more than two cases of variant Creutzfeld-Jacob disease (vCJD) could arise in humans from consumption of a cow infected with BSE. Neil Ferguson and colleagues of the University of Oxford, UK explain in a Brief Communication that their model (which explored more than five million combinations of parameters) also indicates that people under 40 must either be more susceptible to vCJD infection or have been more highly exposed to the infective agent.

The researchers show that the current mortality data are consistent with there being between 63 and 136,000 cases among people known to have a susceptible genotype (about 40% of the population). These upper and lower limits depend on the incubation period of the disease, which is not yet clear. But Ferguson and colleagues’ model implies that a large number - more than 6,000 cases - would only arise if the mean incubation period is about the same length as the average human life expectancy.

CONTACT:

Neil Ferguson tel +44 1865 281 228,
fax +44 1865 281 245,
e-mail neil.ferguson@ceid.ox.ac.uk

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.